Inner Mongolia Huaxin Pharmaceutical Co. Ltd., hereinafter referred to as Huaxin Pharmaceutical, was established in 2019, in Kailu County Industrial Park, Tongliao City, Inner Mongolia through the investment attraction of Tongliao City Government, covering an area of 170 mu. The company is based on the establishment of pharmaceutical intermediates, sterile apis, sterile preparations of research and development, production and sales in one of the veterinary medicine GMP standardized enterprises. In August of the same year, a limited liability company invested or held by natural persons was established with Lu Biao, the legal representative, and the registered capital was 100 million yuan.
The project will be prepared by the end of 2019, with an estimated total investment of 500 million yuan, and the annual output of 500 tons of ceftiofurme, ceftiofurme hydrochloride, ceftioxime sulfate, penicillin sodium, amoxicillin, ampicillin sodium, ampicillin sodium and preparations of antibiotics. After the completion of all the projects, the annual sales revenue will be 800 million yuan, profits and taxes will be 60 million yuan, and more than 300 people will be employed, contributing to the economic development of Inner Mongolia.
In line with the purpose of serving animal husbandry and human health, the company is fully committed to providing zero-tolerance products and actively promoting the development of animal husbandry to ensure food safety, protect life and care for health. Adhering to the quality policy of quality first, reputation first, management-oriented, service sincere, the company has established the whole process of quality control system from raw materials into the factory to products out of the factory. To ensure that the quality activities of enterprises have laws and regulations to follow, so that quality management means and methods to achieve institutionalization, standardization.
Huaxin Pharmaceutical implements the general manager responsibility system, which consists of eight departments: General Handling Office, Production Department, Quality Management Department (Quality Assurance Department, Quality Control Department), Human Resources Department, Safety and Environmental Protection Department, Equipment engineering Department, Finance Department and Supply and Marketing Department. The company will continue to innovate, enhance its core competitiveness, and take the initiative in the market environment.
At present, the development of veterinary medicine in China has entered the normative stage, and the veterinary medicine industry has begun to take shape. Hua xin Pharmaceutical will closely follow the pulse of the veterinary medicine market, establish the brand of Huaxin, and create a lasting foundation. The company strictly implements the requirements of GMP and establishes a modern marketing system. Based on the majority of customers, the company around animal health, food safety to carry out work, adhere to the quality of survival, credibility and development, service to win the future.
Huaxin Pharmaceutical will concentrate on expanding and strengthening the domestic market, improving the market competitiveness, winning the supervision of market institutions and the trust of consumers, occupying an absolute advantage in the future development and competition, striving to pass the CE certification of the European Union and enter the international market.
170 Mu
Located in Tongliao City, Inner Mongolia, the company covers an area of 170 mu
4500 Tons
It plans to build an annual output of 4500 tons of antibiotic products
800Million
Annual sales revenue of 800 million yuan
300 People
More than 300 people will be employed
